Your browser is no longer supported. Please, upgrade your browser.
EOLS Evolus, Inc. daily Stock Chart
Evolus, Inc.
Index- P/E- EPS (ttm)-3.41 Insider Own27.30% Shs Outstand33.72M Perf Week16.41%
Market Cap141.30M Forward P/E- EPS next Y-0.64 Insider Trans-0.47% Shs Float22.53M Perf Month8.22%
Income-98.80M PEG- EPS next Q-0.67 Inst Own43.50% Short Float16.82% Perf Quarter-46.89%
Sales45.40M P/S3.11 EPS this Y-66.00% Inst Trans2.39% Short Ratio4.58 Perf Half Y-67.00%
Book/sh1.86 P/B2.48 EPS next Y71.70% ROA-47.00% Target Price- Perf Year-71.33%
Cash/sh3.25 P/C1.42 EPS next 5Y16.80% ROE-197.30% 52W Range3.12 - 20.27 Perf YTD-62.12%
Dividend- P/FCF- EPS past 5Y- ROI-49.10% 52W High-77.26% Beta-
Dividend %- Quick Ratio5.00 Sales past 5Y- Gross Margin73.10% 52W Low47.99% ATR0.51
Employees220 Current Ratio5.60 Sales Q/Q- Oper. Margin- RSI (14)58.99 Volatility20.01% 10.92%
OptionableYes Debt/Eq1.47 EPS Q/Q-45.70% Profit Margin- Rel Volume2.10 Prev Close4.61
ShortableYes LT Debt/Eq1.47 EarningsFeb 25 BMO Payout- Avg Volume826.40K Price4.61
Recom2.10 SMA2011.93% SMA5012.46% SMA200-57.43% Volume0 Change0.00%
Feb-06-20Resumed Mizuho Buy
Nov-26-19Initiated SVB Leerink Outperform $25
Sep-05-19Resumed Mizuho Buy $30
Jun-28-19Initiated Wells Fargo Market Perform $16
Jun-11-19Initiated Barclays Underweight $13
Mar-20-19Initiated SunTrust Buy $30
Feb-14-19Initiated H.C. Wainwright Buy $37
Jan-29-19Initiated Stifel Buy $27
May-25-20 05:40AM  Evolus Volatility Remains A Mystery, Analyst Highlights Stocks Unique Potential TipRanks
May-14-20 09:50AM  What You Need To Know About The Evolus, Inc. (NASDAQ:EOLS) Analyst Downgrade Today Simply Wall St. -8.33%
May-12-20 05:00AM  Evolus, Inc. (EOLS) Q1 2020 Earnings Call Transcript Motley Fool
May-11-20 04:01PM  Evolus Reports First Quarter 2020 Results and Provides Business Update GlobeNewswire
May-06-20 04:01PM  Evolus to Report First Quarter 2020 Financial Results and Provide a Business Update on Monday, May 11, 2020 GlobeNewswire
Apr-16-20 04:52PM  Evolus Provides Strategic Business Update GlobeNewswire
Apr-05-20 09:55AM  Time To Worry? Analysts Are Downgrading Their Evolus, Inc. (NASDAQ:EOLS) Outlook Simply Wall St.
Mar-04-20 09:08AM  Evolus Provides Update on International Trade Commission (ITC) Case GlobeNewswire -9.17%
Mar-03-20 09:00AM  Evolus to Participate in Barclays 2020 Global Healthcare Conference GlobeNewswire
Feb-28-20 08:43AM  Implied Volatility Surging for Evolus (EOLS) Stock Options Zacks
Feb-25-20 07:00AM  Evolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update GlobeNewswire -7.17%
06:00AM  Evolus, Inc. to Host Earnings Call ACCESSWIRE
Feb-13-20 08:30AM  Evolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-12-20 08:30AM  Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020 GlobeNewswire
Jan-27-20 11:17AM  3 Healthcare Stocks That Offer a Compelling Buying Opportunity TipRanks
09:00AM  Positive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crows Feet Lines Published in Dermatologic Surgery GlobeNewswire
Jan-09-20 09:00AM  Evolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue GlobeNewswire
Jan-06-20 06:25AM  Need To Know: Evolus, Inc. (NASDAQ:EOLS) Insiders Have Been Buying Shares Simply Wall St.
Dec-17-19 04:38PM  Is Evolus, Inc. (EOLS) A Good Stock To Buy? Insider Monkey
Nov-07-19 04:10PM  Evolus to Participate in Stifel Healthcare Conference GlobeNewswire +7.79%
06:50AM  What Kind Of Shareholder Owns Most Evolus, Inc. (NASDAQ:EOLS) Stock? Simply Wall St.
01:18AM  Evolus Announces Pricing of Public Offering of Common Stock GlobeNewswire
Nov-06-19 04:02PM  Evolus Announces Proposed Public Offering of Common Stock GlobeNewswire -10.20%
Nov-04-19 07:00AM  Evolus Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Oct-31-19 02:13PM  Hedge Funds Have Never Been This Bullish On Evolus, Inc. (EOLS) Insider Monkey -5.90%
Oct-28-19 04:05PM  Evolus to Report Third Quarter 2019 Financial Results and Provide a Business Update on Monday, November 4, 2019 GlobeNewswire
Oct-16-19 09:05AM  Evolus and Clarion Medical Technologies Announce First Shipment of Nuceiva (prabotulinumtoxinA) to Customers in Canada GlobeNewswire
Oct-15-19 05:04PM  Allergan (AGN) Shareholders Approve Acquisition by AbbVie Zacks
Oct-01-19 09:09AM  Evolus Receives Approval for Nuceiva in the European Union GlobeNewswire
Sep-27-19 07:14AM  Market Sentiment Around Loss-Making Evolus, Inc. (NASDAQ:EOLS) Simply Wall St. -5.30%
Sep-18-19 09:00AM  Evolus will Participate in Cantor Global Healthcare Conference GlobeNewswire
Sep-04-19 06:00AM  Evolus Announces Successful Completion of the Jeuveau® Experience Treatment (J.E.T) Program GlobeNewswire
Aug-22-19 04:05PM  Evolus to Participate in Two Upcoming Investor Conferences GlobeNewswire
Aug-20-19 11:20AM  Is Evolus (NASDAQ:EOLS) Weighed On By Its Debt Load? Simply Wall St.
Aug-13-19 08:02AM  Evolus Could See Breakout Soon -9.66%
Aug-12-19 11:23AM  Evolus, Inc. (EOLS) Q2 2019 Earnings Call Transcript Motley Fool
07:59AM  UPDATE 1-Evolus reports sales of its Botox rival ahead of expectations Reuters
07:01AM  Evolus says launch of its Botox rival ahead of its expectations Reuters
07:01AM  Evolus Reports Second Quarter 2019 Financial Results GlobeNewswire
06:00AM  Evolus, Inc. to Host Earnings Call ACCESSWIRE
Aug-09-19 07:36AM  What's in Store for Flexible Solutions (FSI) in Q2 Earnings? Zacks
Aug-08-19 07:03AM  Barrick (GOLD) to Post Q2 Earnings: What's in the Cards? Zacks +6.70%
06:39AM  Advance Auto Parts (AAP) to Post Q2 Earnings: What's Up? Zacks
Aug-01-19 08:30AM  Evolus to Report Second Quarter 2019 Financial Results and Provide a Business Update on Monday, August 12, 2019 GlobeNewswire
Jul-30-19 10:22AM  4 Medical Product Stocks Set to Beat This Earnings Season Zacks
Jul-15-19 08:30AM  Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D. GlobeNewswire
Jul-12-19 08:39AM  Will Evolus Continue to Surge Higher? Zacks
Jul-10-19 07:09AM  Evolus Is Shaping Up Nicely, Time to Go Long
Jul-08-19 09:41AM  AbbVie (ABBV) Shares Down So Far This Year: Here's Why Zacks
Jul-01-19 12:49PM  Who Has Been Buying Evolus, Inc. (NASDAQ:EOLS) Shares? Simply Wall St.
12:46PM  If You Had Bought Evolus (NASDAQ:EOLS) Stock A Year Ago, You'd Be Sitting On A 51% Loss, Today Simply Wall St.
Jun-28-19 03:16PM  Evolus Could Turn Into an Attractive Play
Jun-25-19 11:39AM  Allergan acquisition is a major bailout for shareholders, according to analysts MarketWatch
09:48AM  AbbVie Is Buying Allergan and Wall Street Is Doubtful
09:34AM  Allergan Up As Analyst Statement Sparks Business Split Rumors Zacks
09:10AM  Allergan Is a $63 Billion Botox Job for AbbVie Bloomberg
Jun-10-19 09:00AM  Evolus Provides Update on Nuceiva Marketing Authorization Application in Europe GlobeNewswire
Jun-05-19 07:45AM  Evolus Accelerates Next Phase of U.S. Launch of Jeuveau with #NEWTOX NOW Consumer Conversion Program GlobeNewswire +16.20%
May-28-19 04:01PM  Evolus to Participate in Three Upcoming Investor Conferences GlobeNewswire -9.76%
May-21-19 09:00AM  ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt PR Newswire
May-15-19 04:58PM  ALPHAEON Corporation sells 4 million shares in Evolus Inc. PR Newswire
09:00AM  Evolus Announces First Shipment of Jeuveau (prabotulinumtoxinA-xvfs) to Customers in the United States GlobeNewswire
May-08-19 03:17PM  Botox Competitor Aims to Take Market Share as Allergan Stumbles Bloomberg
May-06-19 01:32PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
May-01-19 10:38AM  How Many Evolus, Inc. (NASDAQ:EOLS) Shares Do Institutions Own? Simply Wall St.
Apr-30-19 10:27PM  Evolus, Inc. (EOLS) Q1 2019 Earnings Call Transcript Motley Fool -6.70%
04:01PM  Evolus Reports First Quarter 2019 Financial Results GlobeNewswire
Apr-29-19 08:00AM  Evolus to Participate in Two Upcoming Investor Conferences GlobeNewswire -7.86%
Apr-28-19 11:19PM  Will Pharmacy Services Drive CVS Health's (CVS) Q1 Earnings? Zacks
Apr-26-19 11:14AM  3 Stocks To Watch Ahead Of Earnings Benzinga
08:50AM  Evolus Receives Positive CHMP Opinion for Nuceiva in the European Union GlobeNewswire
Apr-25-19 12:02PM  Harry Boxers three stocks to watch this week MarketWatch
11:38AM  Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings? Zacks
11:08AM  Can Covance Business Growth Aid LabCorp (LH) in Q1 Earnings? Zacks
10:39AM  Can iTotal PS Revenues Drive ConforMIS' (CFMS) Q1 Earnings? Zacks
Apr-24-19 04:05PM  Evolus to Release First Quarter 2019 Financial Results and Provide a Business Update on Tuesday, April 30, 2019 GlobeNewswire
10:01AM  Can Front Line Care Drive Hill-Rom's (HRC) Q2 Earnings? Zacks
Apr-23-19 10:41AM  Can Core Renal Care Unit Drive Baxter's (BAX) Q1 Earnings? Zacks +6.40%
Apr-08-19 07:00AM  Evolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveau and BOTOX® in Aesthetic Surgery Journal GlobeNewswire +5.91%
Apr-03-19 08:16AM  3 Small-Cap Biotech Stocks to Watch Now Motley Fool
Apr-01-19 09:00AM  Evolus Provides Regulatory Update on Nuceiva in the European Union GlobeNewswire
Mar-25-19 04:35PM  Why Penn Virginia, Evolus, and Cousins Properties Slumped Today Motley Fool -11.95%
Mar-21-19 08:19AM  Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus Zacks
08:00AM  Evolus Announces Publication of U.S. Phase III Pivotal Trial Results for Jeuveau in Dermatologic Surgery GlobeNewswire
Mar-20-19 03:25PM  NASH, Allergies and Beauty Stocks: Invest or Not? Zacks -5.49%
Mar-19-19 01:17PM  Why Evolus Stock Is Soaring 12% Higher Today Motley Fool +11.40%
Mar-18-19 04:04PM  Evolus Reports Fourth Quarter and Full Year 2018 Results GlobeNewswire
04:01PM  Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC GlobeNewswire
Mar-15-19 04:01PM  Evolus to Release Fourth Quarter and Full Year 2018 Financial Results and Provide a Business Update on Monday, March 18, 2019 GlobeNewswire
Mar-12-19 01:23PM  Evolus, Inc.s (NASDAQ:EOLS) Path To Profitability Simply Wall St.
Mar-06-19 08:54AM  Implied Volatility Surging for Evolus (EOLS) Stock Options Zacks -7.15%
Feb-27-19 09:00AM  Evolus Appoints Crystal Muilenburg as Vice President Corporate Communications & Public Relations GlobeNewswire +7.64%
Feb-21-19 09:47AM  2 Frustrating Flops, Plus Welcome to the Wrinkle Wars Motley Fool
Feb-20-19 09:08AM  Allergan Responds to Investor's Call for CEO/Chair Role Split Zacks
Feb-08-19 03:11PM  Harry Boxers stocks to watch include maker of Botox competitor MarketWatch -7.61%
10:41AM  Evolus Stockholders May Be Frowning in the Short Run
Feb-07-19 07:45PM  Cramer Remix: If the market drops tomorrow, buy this stock CNBC +20.16%
07:08PM  Aesthetics company behind latest Botox rival was 'designed' to compete with Botox: CEO CNBC Videos
Feb-05-19 04:32PM  Why Leggett & Platt, Mueller Industries, and Evolus Jumped Today Motley Fool +26.00%
04:19PM  Botox Maker Allergan Falls After Tepper's Hedge Fund Challenges Management
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was founded in 2012 and is headquartered in Newport Beach, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Avelar RuiSee RemarksJan 07Sale10.7139,442422,28270,802Jan 08 07:37 PM
Avelar RuiSee RemarksDec 10Option Exercise9.9810,020100,000110,244Dec 11 05:53 PM